Cytokine Release Assay Service
Multiple sclerosis (MS) is characterized by chronic inflammation and demyelination within the central nervous system, stemming from dysregulated immune activation. Cytokines acting as signaling molecules orchestrate this inflammatory cascade. Cytokine release assays (CRAs) enable the precise measurement of cytokine secretion, providing crucial insights into the immunopathogenesis of MS. For further information regarding the products and services provided, project-specific consultation, and pricing, please submit an inquiry here.
CRA in Drug Development
- The Close Association Between MS and Cytokines
The pathological cascade of MS, involving blood-brain barrier (BBB) disruption, inflammatory cell infiltration, and demyelination, is centrally mediated by cytokines such as IL-6 and TNF-α. CRAs allow for the simulation of MS-relevant microenvironments, enabling the evaluation of drug modulation on cytokine networks and preventing excessive immune system activation.
- Key Aspects of CRS Prevention
Immunomodulatory drugs, including monoclonal antibodies, can trigger cytokine release syndrome (CRS) through Fab- or Fc-mediated mechanisms. Our CRA services provide systematic detection of drug-induced cytokine release profiles, identifying potential risk molecules, and delivering crucial data for candidate drug screening.
Multiplex Cytokine Assay Platform
Creative Biolabs offers a cytokine detection platform and expert cytokine detection technology services to support your scientific research needs. Our cytokine detection platform uses fluorescent microspheres coupled with highly specific capture monoclonal antibodies and then adds secondary antibodies to measure the fluorescence intensity of a single microsphere, which can effectively detect multiple cytokines at the same time. The cytokine detection platform has the following features:
- High throughput: Detect multiple indicators simultaneously.
- High efficiency: Short experimental time.
- High sensitivity: ≥0.1 pg/mL.
Fig.1 Production of cytokines and granzyme B after stimulation of peripheral blood mononuclear cells (PBMCs) with SLA for a period of 5 days.1
Creative Biolabs also offers other detection methods for the CRA assay, including but not limited to Real-time quantitative polymerase chain reaction assay, enzyme-linked immunosorbent assay (ELISA), flow cytometry, intracellular cytokine staining (ICS) analysis.
Personalized Solutions for MS Research
Our CRA services offer tailored experimental designs to address your specific MS research needs, including:
- Targeted analysis using patient-derived cells or serum: We can conduct targeted cytokine analysis using cells or serum obtained directly from MS patients.
- Integration with demyelination animal models: Combine in vitro CRA results with in vivo data from demyelination animal models to gain a comprehensive understanding of disease mechanisms.
- Cell-specific cytokine profiling: Analyze cytokine secretion profiles of specific cell subsets, such as Th17 cells and microglia, to dissect the complex immune microenvironment in MS.
Please connect with us today for a customized CRA solution and fortify your drug development pipeline!
Reference
- Carrillo, Eugenia, et al. "Cytokine release assays as tests for exposure to Leishmania, and for confirming cure from leishmaniasis, in solid organ transplant recipients." PLoS neglected tropical diseases 9.10 (2015): e0004179. Distributed under Open Access license CC BY 4.0, without modification.
- iNeuMab™ Anti-FGFR1 Antibody (NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1686) (Cat#: NRP-0422-P1686)
- iNeuMab™ Anti-GD2 Antibody (NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- iNeuMab™ Anti-Amyloid Beta 1-15 Antibody (NRP-0422-P867) (Cat#: NRP-0422-P867)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3503) (Cat#: NRZP-1022-ZP3503)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Anti-GARP Antibody (NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- iNeuMab™ Anti-TREM2 Antibody (NRP-0422-P792) (Cat#: NRP-0422-P792)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Mouse Retinal Ganglion Cells (Cat#: NCL2110P145)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Human Neurons Isolated from Cortex (Cat#: NCL-21P6-023)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)